Gossamer bio announces addition of rainer zimmermann, md, as vp of medical affairs

San diego--(business wire)---- $goss--gossamer bio, inc. (nasdaq: goss), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (pah), today announced that rainer zimmermann, md, has joined the company as vice president of medical affairs. dr. zimmermann brings more than 23 years of experience within the pah/ph space, most recently having served as the global medical lead, medical affairs, pulmonary h.
GOSS Ratings Summary
GOSS Quant Ranking